# FDA Inspection 990167 - Evonik Rexim S.A.S. - September 16, 2016

Source: https://www.keypedia.com/records/fda_inspections/evonik-rexim-sas/60ab9007-dfda-4296-94a8-664c193cb77d
Source feed: FDA_Inspections

> FDA Inspection 990167 for Evonik Rexim S.A.S. on September 16, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 990167
- Company Name: Evonik Rexim S.A.S.
- Inspection Date: 2016-09-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275961 - 2024-03-28](https://www.keypedia.com/records/fda_inspections/evonik-rexim-sas/a1d59a43-54fe-4cda-a999-27f07d8cf639)
- [FDA Inspection 1105851 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/evonik-rexim-sas/a84788ab-dd56-42d8-9791-da6ef5e7c53f)
- [FDA Inspection 754360 - 2011-10-13](https://www.keypedia.com/records/fda_inspections/evonik-rexim-sas/a0c4f944-b9e9-47d6-a3f2-f02be17a4031)

Company: https://www.keypedia.com/companies/evonik-rexim-sas/562e2bfa-9c00-490f-ae81-8fe3f59fe78a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c